Literature DB >> 33587451

Low Thoracic Skeletal Muscle Area Is Not Associated With Negative Outcomes in Patients With COVID-19.

Paulina Moctezuma-Velázquez1, Godolfino Miranda-Zazueta, Edgar Ortiz-Brizuela, María Fernanda González-Lara, Karla Maria Tamez-Torres, Carla Marina Román-Montes, Bruno Alejandro Díaz-Mejía, Esteban Pérez-García, Marco Villanueva-Reza, Víctor Hugo Tovar-Méndez, Carla Medrano-Borromeo, Alejandra Martínez-Valenzuela, Míguel Ángel Jandete-Medina, Bernardo Alonso Martínez-Guerra, Luis Uscanga-Domínguez, José Sifuentes-Osornio, Alfredo Ponce-de-León, Antonio Olivas-Martinez, Carlos Moctezuma-Velázquez.   

Abstract

OBJECTIVE: Sarcopenia has been related to negative outcomes in different clinical scenarios from critical illness to chronic conditions. The aim of this study was to verify whether there was an association between low skeletal muscle index and in-hospital mortality, intensive care unit admission, and invasive mechanical ventilation need in hospitalized patients with COVID-19.
DESIGN: This was a retrospective cohort study of a referral center for COVID-19. We included all consecutive patients admitted to the hospital between February 26 and May 15, 2020, with a confirmed diagnosis of COVID-19. Skeletal muscle index was assessed from a transverse computed tomography image at the level of twelfth thoracic vertebra with National Institutes of Health ImageJ software, and statistical analysis was performed to find an association between skeletal muscle index and in-hospital mortality, need of invasive mechanical ventilation, and intensive care unit admission.
RESULTS: We included 519 patients, the median age was 51 (42-61) yrs, and 115 patients (22%) had low skeletal muscle index. On multivariable analysis, skeletal muscle index was not associated with mortality, intensive care unit admission, or invasive mechanical ventilation need nor in a subanalysis of patients 65 yrs or older.
CONCLUSIONS: Skeletal muscle index determined by computed tomography at the level of twelfth thoracic vertebra was not associated with negative outcomes in hospitalized patients with COVID-19.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33587451     DOI: 10.1097/PHM.0000000000001716

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  9 in total

1.  Impact of Pectoral Muscle Values on Clinical Outcomes in Patients With Severe Covid-19 Disease.

Authors:  Hakan Kardas; Maximilian Thormann; Caroline Bär; Jazan Omari; Andreas Wienke; Maciej Pech; Alexey Surov
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

2.  Prevalence of Sarcopenia in Patients With COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Ying Xu; Jia-Wen Xu; Peng You; Bing-Long Wang; Chao Liu; Ching-Wen Chien; Tao-Hsin Tung
Journal:  Front Nutr       Date:  2022-07-04

Review 3.  Skeletal Muscle and COVID-19: The Potential Involvement of Bioactive Sphingolipids.

Authors:  Elisabetta Meacci; Federica Pierucci; Mercedes Garcia-Gil
Journal:  Biomedicines       Date:  2022-05-04

Review 4.  Prevalence and prognostic value of preexisting sarcopenia in patients with mechanical ventilation: a systematic review and meta-analysis.

Authors:  Tingting Jiang; Taiping Lin; Xiaoyu Shu; Quhong Song; Miao Dai; Yanli Zhao; Li Huang; Xiangping Tu; Jirong Yue
Journal:  Crit Care       Date:  2022-05-16       Impact factor: 19.334

5.  Prognostic Role of the Pectoralis Musculature in Patients with COVID-19. A Multicenter Study.

Authors:  Alexey Surov; Hakan Kardas; Giulia Besutti; Massimo Pellegrini; Marta Ottone; Mehmet Ruhi Onur; Firat Atak; Ahmet Gurkan Erdemir; Elif Hocaoglu; Ömer Yıldız; Ercan Inci; Eda Cingöz; Mehmet Cingöz; Memduh Dursun; İnan Korkmaz; Çağrı Orhan; Alexandra Strobel; Andreas Wienke; Maciej Pech
Journal:  Acad Radiol       Date:  2022-05-16       Impact factor: 5.482

6.  Nutritional Risk Assessment Scores Effectively Predict Mortality in Critically Ill Patients with Severe COVID-19.

Authors:  Constantin Bodolea; Andrada Nemes; Lucretia Avram; Rares Craciun; Mihaela Coman; Mihaela Ene-Cocis; Cristina Ciobanu; Dana Crisan
Journal:  Nutrients       Date:  2022-05-18       Impact factor: 6.706

7.  Computed tomography-defined body composition as prognostic markers for unfavourable outcomes and in-hospital mortality in coronavirus disease 2019.

Authors:  Hans-Jonas Meyer; Andreas Wienke; Alexey Surov
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-12       Impact factor: 12.910

8.  Anthropometric analysis of body habitus and outcomes in critically ill COVID-19 patients.

Authors:  Balázs Poros; Andrea Sabine Becker-Pennrich; Bastian Sabel; Hans Joachim Stemmler; Dietmar Wassilowsky; Thomas Weig; Ludwig Christian Hinske; Bernhard Zwissler; Jens Ricke; Dominik J Hoechter
Journal:  Obes Med       Date:  2021-07-03

9.  Coronavirus disease 2019 (Covid-19) outcomes in patients with sarcopenia: A meta-analysis and meta-regression.

Authors:  Yusak Mangara Tua Siahaan; Vinson Hartoyo; Timotius Ivan Hariyanto; Andree Kurniawan
Journal:  Clin Nutr ESPEN       Date:  2022-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.